Showing 1 - 1 results of 1 for search 'Mehrdad Payandeh', query time: 0.01s Refine Results
  1. 1
    Polatuzumab vedotin combined with bendamustine and rituximab for relapsed/refractory diffuse large B-cell lymphoma: A systematic review protocol.

    Polatuzumab vedotin combined with bendamustine and rituximab for relapsed/refractory diffuse large B-cell lymphoma: A systematic review protocol. by Mohammadreza Eslami, Mahdi Mehrabi, Mehrdad Payandeh, Fakhredin Saba

    Published 2024-01-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: